Torii Pharmaceutical Co., Ltd.
TRXPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $209,135,061,680 | $187,345,612,497 | $174,208,804,057 | $158,687,955,238 |
| - Cash | $3,319 | $5,004 | $20,420 | $27,374 |
| + Debt | $429 | $244 | $524 | $486 |
| Enterprise Value | $209,135,058,790 | $187,345,607,737 | $174,208,784,161 | $158,687,928,350 |
| Revenue | $60,425 | $54,638 | $48,894 | $46,987 |
| % Growth | 10.6% | 11.7% | 4.1% | – |
| Gross Profit | $26,707 | $22,758 | $23,378 | $24,339 |
| % Margin | 44.2% | 41.7% | 47.8% | 51.8% |
| EBITDA | $7,133 | $6,052 | $5,975 | $5,047 |
| % Margin | 11.8% | 11.1% | 12.2% | 10.7% |
| Net Income | $5,042 | $4,119 | $3,944 | $3,374 |
| % Margin | 8.3% | 7.5% | 8.1% | 7.2% |
| EPS Diluted | 179.46 | 146.57 | 140.38 | 120.11 |
| % Growth | 22.4% | 4.4% | 16.9% | – |
| Operating Cash Flow | $3,639 | -$3,123 | $2,420 | -$156 |
| Capital Expenditures | -$180 | -$216 | -$281 | -$374 |
| Free Cash Flow | $3,459 | -$3,339 | $2,139 | -$530 |